Japan, Feb. 27 -- INHIBRX BIOSCIENCES INC has got intellectual property rights for 'CLEC12A BINDING POLYPEPTIDES AND USES THEREOF.' Other related details are as follows:

Application Number: JP,2024-140657

Category (FI): C07K19/00,C12N5/10,C12N1/15,C12N15/63@Z,C07K16/18,A61K47/68,A61K39/395@T,A61K45/00,A61P43/00,121,C12N1/19,C12N1/21,A61P35/02,A61P35/00,C12N15/13

Stage: PROBLEM TO BE SOLVED: To provide CLEC12a-binding polypeptides and methods of using CLEC12a-binding polypeptides to treat, for example, leukemia.SOLUTION: There are provided herein, VHH-containing polypeptides that bind CLEC12a, and uses of the VHH-containing polypeptides.SELECTED DRAWING: None (Grant)

Filing Date: Aug. 22, 2024

Publication Date: Nov. 26, 2024

The origin...